Annovis Bio

Penny Stocks Biotech Stocks Healthcare Stocks

$1.93

+0.01 (+0.52%)

As of Jul 4, 2:21 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +649.2% upside

Low Target $8.98

Average Target $14.46

High Target $17.59

Current Price $1.93

Current
$1.93

Target
$14.46

$8.98 $14.46 avg $17.59

Scenario Analysis

Bear Case

$8.98

365.3%

Low target

Base Case

$14.46

+649.2%

Avg target

Bull Case

$17.59

+811.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$5.50

-64.9% from high

52-Week Low

$1.54

+25.3% from low

Target vs 52W High

$14.46

+162.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%